Published in Phys Med Biol on October 04, 2005
Fast, accurate and shift-varying line projections for iterative reconstruction using the GPU. IEEE Trans Med Imaging (2009) 1.74
Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults. Neuroimage (2015) 1.48
Analytic system matrix resolution modeling in PET: an application to Rb-82 cardiac imaging. Phys Med Biol (2008) 1.30
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. IEEE Trans Med Imaging (2008) 1.29
Optimization of Rb-82 PET acquisition and reconstruction protocols for myocardial perfusion defect detection. Phys Med Biol (2009) 1.13
Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development. Neuropsychopharmacology (2012) 1.11
Bayesian PET image reconstruction incorporating anato-functional joint entropy. Phys Med Biol (2009) 1.03
Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals. Med Phys (2012) 1.02
History of childhood adversity is positively associated with ventral striatal dopamine responses to amphetamine. Psychopharmacology (Berl) (2014) 0.99
Acceleration of the direct reconstruction of linear parametric images using nested algorithms. Phys Med Biol (2010) 0.92
Online detector response calculations for high-resolution PET image reconstruction. Phys Med Biol (2011) 0.90
Direct 4D parametric imaging for linearized models of reversibly binding PET tracers using generalized AB-EM reconstruction. Phys Med Biol (2012) 0.89
3.5D dynamic PET image reconstruction incorporating kinetics-based clusters. Phys Med Biol (2012) 0.88
individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects. Pain Med (2013) 0.86
The Role of Dopamine in Value-Based Attentional Orienting. Curr Biol (2016) 0.83
Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation. Phys Med Biol (2013) 0.82
Anatomy assisted PET image reconstruction incorporating multi-resolution joint entropy. Phys Med Biol (2014) 0.79
Anatomy-guided brain PET imaging incorporating a joint prior model. Phys Med Biol (2015) 0.78
Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. PLoS One (2014) 0.77
A theoretical model for EM-ML reconstruction algorithms applied to rotating PET scanners. Phys Med Biol (2009) 0.75
A scatter and randoms weighted (SRW) iterative PET reconstruction. Med Phys (2011) 0.75
Deep reconstruction model for dynamic PET images. PLoS One (2017) 0.75
Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment. Hum Brain Mapp (2017) 0.75
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain (2005) 2.40
PET performance measurements using the NEMA NU 2-2001 standard. J Nucl Med (2002) 2.06
Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci (2011) 1.82
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain (2003) 1.70
Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls. Med Phys (2013) 1.69
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain (2004) 1.65
Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats. J Neurosci (2012) 1.57
Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry (2010) 1.57
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology (2013) 1.50
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry (2010) 1.45
NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med (2012) 1.38
Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res (2002) 1.36
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. IEEE Trans Med Imaging (2008) 1.29
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain (2011) 1.20
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann Neurol (2011) 1.19
Technical performance evaluation of a human brain PET/MRI system. Eur Radiol (2012) 1.14
Manganese-52 positron emission tomography tracer characterization and initial results in phantoms and in vivo. Med Phys (2013) 1.07
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry (2002) 1.03
Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab (2011) 0.99
Problems created in attenuation-corrected SPECT images by artifacts in attenuation maps: a simulation study. J Nucl Med (2005) 0.99
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol (2004) 0.98
Advances in imaging in Parkinson's disease. Lancet Neurol (2011) 0.98
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiol Aging (2011) 0.92
Positron emission tomography kinetic modeling algorithms for small animal dopaminergic system imaging. Synapse (2010) 0.91
Direct 4D parametric imaging for linearized models of reversibly binding PET tracers using generalized AB-EM reconstruction. Phys Med Biol (2012) 0.89
Trials of neuroprotective therapies for Parkinson's disease: problems and limitations. Parkinsonism Relat Disord (2010) 0.87
Quantification accuracy and partial volume effect in dependence of the attenuation correction of a state-of-the-art small animal PET scanner. Phys Med Biol (2012) 0.86
Scanning rats on the high resolution research tomograph (HRRT): a comparison study with a dedicated micro-PET. Med Phys (2012) 0.86
Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. Mol Imaging Biol (2006) 0.85
A scatter-corrected list-mode reconstruction and a practical scatter/random approximation technique for dynamic PET imaging. Phys Med Biol (2007) 0.85
The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling. PLoS One (2013) 0.85
Visualizing vesicular dopamine dynamics in Parkinson's disease. Synapse (2009) 0.85
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. Acta Neuropathol Commun (2015) 0.84
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function. Synapse (2010) 0.83
Positron emission tomography after fetal transplantation in Huntington's disease. Ann Neurol (2005) 0.83
System matrix modelling of externally tracked motion. Nucl Med Commun (2008) 0.83
Commentary: an eye on PET quantification. Mol Imaging Biol (2015) 0.82
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry (2002) 0.82
An analytical scatter correction for singles-mode transmission data in PET. IEEE Trans Med Imaging (2008) 0.82
Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse (2003) 0.82
Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism. Mov Disord (2014) 0.81
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers. Mov Disord (2014) 0.81
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET. J Cereb Blood Flow Metab (2012) 0.81
Novel spatial analysis method for PET images using 3D moment invariants: applications to Parkinson's disease. Neuroimage (2012) 0.80
Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis. EJNMMI Res (2013) 0.79
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA. Neuroimage (2012) 0.78
Frame-to-frame image realignment assessment tool for dynamic brain positron emission tomography. Med Phys (2011) 0.78
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET. Neuroimage (2011) 0.78
Development and evaluation of a LOR-based image reconstruction with 3D system response modeling for a PET insert with dual-layer offset crystal design. Phys Med Biol (2013) 0.78
Positron emission tomography study of the effects of tryptophan depletion on brain serotonin(2) receptors in subjects recently remitted from major depression. Arch Gen Psychiatry (2012) 0.77
Monte Carlo modelling of singles-mode transmission data for small animal PET scanners. Phys Med Biol (2007) 0.77
Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism. Mov Disord (2012) 0.77
Impact of contamination from scattered photons in singles-mode transmission data on quantitative small-animal PET imaging. J Nucl Med (2008) 0.76
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies. Mov Disord (2006) 0.75
Functional neuroimaging in Parkinson's disease. Expert Opin Med Diagn (2011) 0.75
Multi-isotope SPECT imaging of the (225)Ac decay chain: feasibility studies. Phys Med Biol (2017) 0.75
PET Image Reconstruction and Deformable Motion Correction Using Unorganized Point Clouds. IEEE Trans Med Imaging (2017) 0.75
Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice. J Nucl Med (2011) 0.75
Brain serotonin-2 receptors in acute mania. Br J Psychiatry (2010) 0.75
Incorporating HYPR de-noising within iterative PET reconstruction (HYPR-OSEM). Phys Med Biol (2017) 0.75